{"prediction": {"id": "85c541f4-eaf1-5e07-9454-07f0c2942444", "work_id": "ab4e391e-6ab3-5ff9-9ed9-06f787f5913e", "study_id": "4ac82e2c-09d1-586d-a620-73797e282326", "kind": "Virtual population exposure comparison", "pages": [3], "version": "Accepted manuscript", "source_work_id": "ab4e391e-6ab3-5ff9-9ed9-06f787f5913e", "title": "Modelled plasma concentrations of pemafibrate with co-administered typical cytochrome P450 inhibitors clopidogrel, fluconazole or clarithromycin predicted by physiologically based pharmacokinetic modelling in virtual populations.", "doi": "10.1080/00498254.2020.1793030", "pdf_sha256": "1bd923b5f7dc647338ea63497497af9fa24dbbe7d0302bb65f8d4440844d07b2", "physical_page_count": 24}, "fields": {"measured_variable": {"value": "plasma_drug_exposure", "source_basis": "verified_profile", "pages": [3]}, "metric": {"value": "fold_change", "source_basis": "verified_profile", "pages": [3]}, "reference_type": {"value": "simulated_against_baseline", "source_basis": "verified_profile", "pages": [3]}, "scenario": {"value": "within_model_scenario_comparison", "source_basis": "verified_profile", "pages": [3]}}, "endpoints": [{"term": "pharmacokinetics", "label": "Pharmacokinetics and drug exposure"}], "validations": [{"id": "3698f72b-455d-5d31-b020-f088bb60ab0e", "claim_id": "85c541f4-eaf1-5e07-9454-07f0c2942444", "coverage": "related_context", "support": "not_assessed", "source": "unknown", "overlap": "unknown", "comparability": "partial", "statistics": "not_reported", "anchors": [{"work_id": "ab4e391e-6ab3-5ff9-9ed9-06f787f5913e", "version": "Accepted manuscript", "pages": [9]}]}], "model_resources": {"total": 0, "page": 1, "limit": 50, "rows": [], "review_status": "indexed_source"}}